{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:26:42Z","timestamp":1794961602957,"version":"4.9.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate the efficacy and safety of using off-label direct oral anticoagulants (DOACs) compared to warfarin for treating left ventricular (LV) thrombi using inverse probability-of-treatment weighting (IPTW) analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An observational study of 302 eligible patients with newly diagnosed LV thrombi was conducted at a tertiary referral center from January 2020 to December 2023. Of the 302 patients, 183 received treatment with DOACs, while 119 were treated with warfarin. The primary endpoint was defined as the complete resolution of the thrombus within one month. The secondary endpoints were defined as the complete resolution of the thrombus within six months along with the following events, including minor and major bleeding events, a systemic embolism, transient ischemic attack, stroke, and all-cause mortality. Alongside individual endpoints, a composite endpoint involving ischemic stroke or mortality was also examined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>IPTW estimates suggested that DOACs were significantly more effective than warfarin in resolving LV thrombus within one month (RR: 1.38; 95% CI: 1.14\u20131.66; <jats:italic>p<\/jats:italic>-value: &amp;lt;0.001). However, there were no significant differences between the two groups in all secondary endpoints, except that DOACs were significantly associated with a lower incidence of the composite outcome of ischemic stroke and all-cause mortality (RR: 0.96; 95% CI: 0.93\u20130.99; <jats:italic>p<\/jats:italic>-value: 0.040). In DOAC subgroup analysis, only rivaroxaban demonstrated earlier and superior resolution of LV thrombus with non-inferior safety when compared to warfarin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>DOACs, specifically rivaroxaban, could be a promising therapeutic alternative for treating LV thrombi. Further research through randomized clinical trials is necessary to confirm our findings.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2025.1465866","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:34:54Z","timestamp":1745818494000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and safety of off-label direct oral anticoagulants vs. warfarin for left ventricular thrombus: an inverse probability of treatment weighting analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Taha","family":"Al-Maimoony","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khairallah","family":"Al-Matari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulhafeedh","family":"Al-Habeet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouradden Noman","family":"Aljaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Al-Marwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah","family":"Al-Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/atm-20-7839","article-title":"Management of left ventricular thrombus: a narrative review","volume":"9","author":"Rodriguez","year":"2021","journal-title":"Ann Transl Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3389\/fcvm.2022.944687","article-title":"Clinical characteristics and prognosis of patients with left ventricular thrombus in East China","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijcha.2019.100395","article-title":"Incidence and predictors of left ventricular thrombus formation following acute ST-segment elevation myocardial infarction: a serial cardiac MRI study","volume":"24","author":"Phan","year":"2019","journal-title":"IJC Heart & Vasculature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1161\/CIR.0000000000001092","article-title":"Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association","volume":"146","author":"Levine","year":"2022","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1016\/j.jacc.2019.01.031","article-title":"Left ventricular thrombus: contemporary etiologies, treatment strategies, and outcomes","volume":"73","author":"McCarthy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/ehjcvp\/pvaa066","article-title":"Left ventricular thrombosis: new perspectives on an old problem","volume":"7","author":"Massussi","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.jacc.2021.01.049","article-title":"Comparative study of oral anticoagulation in left ventricular thrombi (No-LVT trial)","volume":"77","author":"Abdelnabi","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.cjco.2022.12.003","article-title":"Apixaban in patients with post-myocardial infarction left ventricular thrombus: a randomized clinical trial","volume":"5","author":"Youssef","year":"2023","journal-title":"CJC Open"},{"key":"B9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12959-024-00585-9","article-title":"Comparative effectiveness and safety of DOACs vs. VKAs in treatment of left ventricular thrombus-a meta-analysis update","volume":"22","author":"Hu","year":"2024","journal-title":"Thromb J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.repc.2021.11.013","article-title":"Effect of direct oral anticoagulants versus vitamin K antagonists or warfarin in patients with left ventricular thrombus outcomes: a systematic review and meta-analysis","volume":"42","author":"da Silva Ferreira","year":"2023","journal-title":"Rev Port Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/ehjcvp\/pvaa096","article-title":"The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction","volume":"7","author":"Jones","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"B12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s43044-021-00164-7","article-title":"Rivaroxaban versus warfarin for the management of left ventricle thrombus","volume":"73","author":"Albabtain","year":"2021","journal-title":"Egypt Heart J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European society of cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/ehjcvp\/pvab057","article-title":"Apixaban vs. warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial","volume":"8","author":"Alcalai","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"B15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2217\/cer-2020-0013","article-title":"Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants","volume":"9","author":"Allan","year":"2020","journal-title":"J Comp Eff Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1161\/STROKEAHA.108.192218","article-title":"Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American heart association\/American stroke association stroke council; council on cardiovascular surgery and anesthesia; council on cardiovascular radiology and intervention; council on cardiovascular nursing; and the interdisciplinary council on peripheral vascular disease: the American academy of neurology affirms the value of this statement as an educational tool for neurologists","volume":"40","author":"Easton","year":"2009","journal-title":"Stroke"},{"key":"B18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1524-4733.2009.00671.x","article-title":"Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals","volume":"13","author":"Xu","year":"2010","journal-title":"Value Health"},{"key":"B19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ckj\/sfab158","article-title":"An introduction to inverse probability of treatment weighting in observational research","volume":"15","author":"Chesnaye","year":"2022","journal-title":"Clin Kidney J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2188\/jea.JE20210145","article-title":"Using propensity scores for causal inference: pitfalls and tips","volume":"31","author":"Shiba","year":"2021","journal-title":"J Epidemiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-017-0338-0","article-title":"Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance","volume":"17","author":"Nguyen","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.jacc.2020.01.057","article-title":"Antithrombotic therapy for patients with left ventricular mural thrombus","volume":"75","author":"Lattuca","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1002\/ehf2.14084","article-title":"Systematic review of efficacy of direct oral anticoagulants and vitamin K antagonists in left ventricular thrombus","volume":"9","author":"Huang","year":"2022","journal-title":"ESC Heart Fail"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/01.CIR.75.5.1004","article-title":"Increased embolic risk in patients with left ventricular thrombi","volume":"75","author":"Stratton","year":"1987","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/0735-1097(93)90409-T","article-title":"Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis","volume":"22","author":"Vaitkus","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.hrtlng.2024.04.019","article-title":"Evaluation of the safety and efficacy of direct oral anticoagulants compared with vitamin-k antagonists in the treatment of left ventricular thrombosis. A systematic review and meta-analysis","volume":"67","author":"Mehrpooya","year":"2024","journal-title":"Heart Lung"},{"key":"B28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11239-018-1656-8","article-title":"A meta-summary of case reports of non-vitamin K antagonist oral anticoagulant use in patients with left ventricular thrombus","volume":"46","author":"Leow","year":"2018","journal-title":"J Thromb Thrombolysis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"13203","DOI":"10.1038\/s41598-023-40389-x","article-title":"Trial sequential analysis of efficacy and safety of direct oral anticoagulants and vitamin K antagonists against left ventricular thrombus","volume":"13","author":"Kitano","year":"2023","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"884","DOI":"10.21037\/jtd-23-1582","article-title":"Direct oral anticoagulants compared with warfarin in patients with left ventricular thrombus: a cohort study from China","volume":"16","author":"Zhou","year":"2024","journal-title":"J Thorac Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/jamacardio.2020.0652","article-title":"Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi","volume":"5","author":"Robinson","year":"2020","journal-title":"JAMA cardiology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.12669\/pjms.36.4.1972","article-title":"Diagnosis and risk stratification of coronary artery disease in Yemeni patients using treadmill test","volume":"9","author":"Aljaber","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"B33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.33805\/2573-3877.134","article-title":"The prevalence of left ventricular thrombus among heart failure patients admitted to Kuwait teaching hospital in Sanaa city between January 2014\u20132017","volume":"4","author":"Khaled","year":"2019","journal-title":"Nurs Health Care"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1093\/ehjci\/jeaa244","article-title":"Left ventricular thrombus on cardiovascular magnetic resonance imaging in non-ischaemic cardiomyopathy","volume":"22","author":"Hooks","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/ehf2.14369","article-title":"Factors influencing left ventricular thrombus resolution and its significance on clinical outcomes","volume":"10","author":"Kim","year":"2023","journal-title":"ESC Heart Fail"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1465866\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:34:56Z","timestamp":1745818496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1465866\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":35,"alternative-id":["10.3389\/fcvm.2025.1465866"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1465866","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fcvm.2025.1465866.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fcvm.2025.1465866.s002","asserted-by":"subject"}]},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"article-number":"1465866"}}